You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 9, September 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Laboratory Sciences
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Arachidonic Acid Metabolites After Excimer Laser Corneal Surgery

Andrew F. Phillips, MD; Karin Szerenyi, MD; Mauro Campos, MD; Ronald R. Krueger, MD; Peter J. McDonnell, MD

Arch Ophthalmol. 1993;111(9):1273-1278.


Abstract

Objective
We investigated early mediators of inflammation following excimer laser ablation in a rabbit cornea model. The ability of topical anti-inflammatory agents to influence these responses was also examined.

Methods
Adult New Zealand white rabbits were subjected to photorefractive keratectomy with a 193-nm argon fluoride excimer laser. Prostaglandin E2 and leukotriene B4 levels were measured using an enzyme immunoassay, and leukocyte infiltration was determined histologically.

Results
Prostaglandin E2 production was rapid and sustained, but we were unable to detect the presence of leukotriene B4. Relative to control, postoperative topical diclofenac sodium treatment caused a significant decrease in prostaglandin E2 levels and a significant increase in corneal leukocytes at 10 hours. Fluorometholone treatment did not significantly alter prostaglandin E2 levels but markedly depressed leukocyte ingress.

Conclusions
Diclofenac reduces prostaglandin E2 levels but not leukocyte infiltration in the cornea following photorefractive keratectomy and thus may be useful clinically to reduce postsurgical pain.



Author Affiliations

From the Doheny Eye Institute and the Department of Ophthalmology, University of Southern California School of Medicine, Los Angeles.


Footnotes

The authors and their family members have no financial or proprietary interest in any of the materials or methods described in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topical Diclofenac Sodium Decreases the Substance P Content of Tears
Yamada et al.
Arch Ophthalmol 2002;120:51-54.
ABSTRACT | FULL TEXT  

Effect of Topical Ascorbic Acid on Free Radical Tissue Damage and Inflammatory Cell Influx in the Cornea After Excimer Laser Corneal Surgery
Kasetsuwan et al.
Arch Ophthalmol 1999;117:649-652.
ABSTRACT | FULL TEXT  

Oxygen free radical damage in the cornea after excimer laser therapy
Hayashi et al.
Br J Ophthalmol 1997;81:141-144.
ABSTRACT | FULL TEXT  

Effect of Diclofenac, Ketorolac, and Fluorometholone on Arachidonic Acid Metabolites Following Excimer Laser Corneal Surgery
Phillips et al.
Arch Ophthalmol 1996;114:1495-1498.
ABSTRACT  

Corneal Sensitivity and Burning Sensation: Comparing Topical Ketorolac and Diclofenac
Seitz et al.
Arch Ophthalmol 1996;114:921-924.
ABSTRACT  

Prevention of Keratocyte Loss After Corneal Deepithelialization in Rabbits
Nassaralla et al.
Arch Ophthalmol 1995;113:506-511.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.